Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
HemoCath
HemoCath is an early-stage MedTech company pioneering innovations in Digital Medicine for critically ill patients and those with heart failure. Their flagship product, the Swan-HemoCath™ Critical…
HemoCath
HemoCath is an early-stage MedTech company pioneering innovations in Digital Medicine for critically ill patients and those with heart failure. Their flagship product, the Swan-HemoCath™ Critical…
TL;DR
Stage: Early-stage MedTech / Digital Health
Flagship product: HemoCath PA catheter + HemoDynamix / HemoDynamix AI cloud
Target indication: Acute decompensated heart failure (ADHF)
Regulatory status: Not approved for clinical use
Employees: Approximately 5
Company Overview
Problem Domain
Real-time hemodynamic monitoring and clinical decision support for acute decompensated heart failure and critically ill patients.
Industry
MedTech / Digital Health
Funding Track Record
$1.4M
Dealroom lists a seed funding entry in April 2020.
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week